What’s the Impact of Mid-Revenue Cycle Leakage on the Healthcare System?

 

In the intricate dynamics of healthcare systems, financial resiliency continues to be a primary challenge, and the issue of mid-revenue cycle leakage is a daunting problem that bleeds millions of dollars from the industry every year. Amidst a global healthcare crisis, efficient utilization of resources has never been more critical. As Fran Jurcak, Chief Clinical Officer at Iodine Software, notes, a staggering $4.5M to $1M is lost in revenue in an average 250-bed hospital due to inefficient workflows. This alarming figure underscores the urgency of the question: how is mid-revenue cycle leakage impacting the healthcare system, and how best to handle the situation?

In the latest episode of Iodine Intelligence from Iodine Software, Jurcak tackles this pressing question head-on, engaging in a detailed conversation with Kati Beisel, Director of Health Information for INTEGRIS Health.

Jurcak and Beisel’s discussion includes:

  • The substantial costs and impacts of mid-revenue cycle leakage on day-to-day operations, budget planning, resource allocation, patient outcomes, and staffing initiatives.
  • The challenge of quantifying costs and the significant revenue losses incurred by hospitals due to inefficient workflows.
  • Potential solutions, including Iodine’s software solutions, to improve Clinical Documentation Improvement (CDI) and reduce mid-revenue cycle leakage.

Kati Beisel is a leader in healthcare information management, serving as the Director of Health Information for INTEGRIS Health, Oklahoma’s most extensive state-owned not-for-profit healthcare system. Beisel’s expertise and insights into the issues of revenue leakage and CDI come from years of experience in the field. Her dedication to improving the quality of patient care and her innovative approaches to addressing leakage is a testament to her commitment to excellence in healthcare.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…